Novartis Investigational H5N1 vaccine

BIOLOGICAL2 trials

Sponsors

Seqirus

Conditions

Flu, AvianFlu, HumanInfluenzaInfluenza A Virus, H5N1 SubtypeInfluenza, Human

Phase 3

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions

CompletedNCT02091908

SeqirusInfluenza, Human

Start: 2014-04-30End: 2015-04-30Updated: 2016-11-04

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

CompletedNCT02107807

SeqirusFlu, Avian, Flu, Human, Influenza +2

Start: 2014-04-30End: 2015-05-31Updated: 2016-05-09